Discover
DTIL
Precision BioSciences, Inc.
6.67
1 x 6.56
2 x 8.88
bid
ask
+
0.00
0.00%
2 @ 07:30 PM
6.64 -0.03 (0.44%)
| Ytd | 60.34% | |
| 1y | 35.85% |
6.59
day range
6.87
3.57
52 week range
9.28
| Open | 6.65 | Prev Close | 6.67 | Low | 6.59 | High | 6.87 | Mkt Cap | 184.10M |
| Vol | 241.37K | Avg Vol | 398.05K | EPS | -1.32 | P/E | N/A | Forward P/E | -0.66 |
| Beta | 1.69 | Short Ratio | 2.42 | Inst. Own | 44.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 7.66 | 200-d Avg | 6.23 | 1yr Est | 33.60 |
| Income Statement | |||
| Operating Expenses | 19.16M | ||
| Research and Development Expense | 12.39M | ||
| Selling, General and Administrative Expense | 6.77M | ||
| Operating Income | -19.16M | ||
| Interest Expense | 300.00K | ||
| Net Income | -32.65M | ||
| Net Income Common Stock | -32.65M | ||
| Net Income Common Stock (USD) | -32.65M | ||
| Consolidated Income | -32.65M | ||
| Earnings per Basic Share | -1.26 | ||
| Earnings per Basic Share (USD) | -1.26 | ||
| Earnings per Diluted Share | -1.26 | ||
| Earning Before Interest & Taxes (EBIT) | -32.35M | ||
| Earning Before Interest & Taxes (USD) | -32.35M | ||
| Weighted Average Shares | 25.86M | ||
| Weighted Average Shares Diluted | 25.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 112.41M | ||
| Cash and Equivalents (USD) | 112.41M | ||
| Investments | 2.22M | ||
| Investments Current | 1.47M | ||
| Investments Non-Current | 744.00K | ||
| Current Assets | 91.55M | ||
| Property, Plant & Equipment Net | 6.08M | ||
| Total Assets | 125.92M | ||
| Debt Current | 1.61M | ||
| Total Debt | 28.10M | ||
| Current Liabilities | 7.14M | ||
| Debt Non-Current | 26.49M | ||
| Total Liabilities | 80.63M | ||
| Accumulated Retained Earnings (Deficit) | -579.28M | ||
| Shareholders Equity | 45.29M | ||
| Shareholders Equity (USD) | 45.29M | ||
| Assets Non-Current | 34.37M | ||
| Total Debt (USD) | 28.10M | ||
| Deferred Revenue | 10.00M | ||
| Goodwill and Intangible Assets | 1.09M | ||
| Liabilities Non-Current | 73.49M | ||
| Trade and Non-Trade Payables | 828.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 603.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.44M | ||
| Capital Expenditure | 1000 | ||
| Net Cash Flow from Investing | 1000 | ||
| Net Cash Flow from Operations | -13.44M | ||
| Share Based Compensation | 1.84M | ||